CASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. (CASI) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 93 transactions totaling $51.8M, demonstrating a bullish sentiment with $51.8M in net insider flow. The most recent transaction on Sep 8, 2022 involved a purchase of 33,300 shares valued at $142.5K.
CASI Insider Activity Summary
Who Is Buying CASI Stock?
No significant insider buying has been recorded for CASI in the recent period.
Who Is Selling CASI Stock?
No significant insider selling has been recorded for CASI in the recent period.
Is CASI Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CASI is bullish with an Insider Alignment Score of 100/100 and a net flow of $51.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CASI Frequently Asked Questions
Understanding CASI Insider Activity
Insider trading at CASI Pharmaceuticals, Inc. (CASI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading CASI stock, having executed 93 transactions in the past 90 days. The most active insider is Wei-wu He (Executive), who has made 36 transactions totaling $34.3M.
Related Tools
Track CASI Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at CASI file new Form 4 transactions